Tumor hypoxia and altered pH were shown to reduce bioluminescent signals[311,312] which led to the development of specific bioluminescent probes for tumor hypoxia using CYP450 reductase[313] and a HIF-1a reporter construct[314]. Here, HIF1A is linked to neoplasm.